GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 49 filers reported holding GENERATION BIO CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,352,045 | -31.1% | 356,740 | 0.0% | 0.26% | -19.6% |
| Q2 2023 | $1,962,070 | +18.5% | 356,740 | -7.4% | 0.33% | +2.8% |
| Q1 2023 | $1,655,801 | +53.9% | 385,070 | +40.6% | 0.32% | +52.9% |
| Q4 2022 | $1,075,983 | +142.3% | 273,787 | +1557.1% | 0.21% | +477.8% |
| Q2 2021 | $444,000 | -27.6% | 16,522 | -23.2% | 0.04% | -21.7% |
| Q1 2021 | $613,000 | -43.3% | 21,522 | -38.5% | 0.05% | -50.5% |
| Q3 2020 | $1,082,000 | -89.9% | 35,000 | -93.2% | 0.09% | -90.6% |
| Q2 2020 | $10,737,000 | – | 511,300 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |